University Oncology Associates — Clovis, California

Public research footprint of University Oncology Associates, compiled from the ClinicalTrials.gov public registry.

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Stage IB Lung Non-Small Cell Carcinoma AJCC v7 · Recurrent Ovarian Carcinoma · B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1 · EBV-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified

Recently updated registry entries

NCT03150693 — Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly… (Recruiting)
NCT02194738 — Genetic Testing in Screening Patients With Stage IB-IIIA Non-small Cell Lung Cancer That… (Active Not Recruiting)
NCT03866382 — Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at University Oncology Associates?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 06, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.